SNB rates not yet restrictive enough to tame prices, Jordan says
The Swiss National Bank’s interest-rate moves haven’t yet fully tamed inflation, according to its President Thomas Jordan.
This content was published on
1 minute
Bloomberg
“Monetary policy is still not restrictive enough to anchor inflation in the area of price stability,” Jordan said on Wednesday in Chur, Switzerland. “We cannot exclude that we have to further tighten monetary policy.”
Switzerland’s central bank has lifted rates by 225 basis points since last June. While the SNB – which next meets on June 22 – kicked off its tightening cycle earlier that the European Central Bank, its schedule of just one meeting a quarter means it has raised borrowing costs by less than its euro-area counterpart.
Comparatively slow Swiss inflation has also allowed this less aggressive stance: Consumer-price growth in April was just 2.6% – fraction of the rate in the surrounding euro area. Still, the SNB sees inflation staying at 2% or higher through 2025, hovering on the upper edge of its target range.
“If the inflation forecast is significantly above the area of price stability, then monetary policy is too loose,” Jordan said, adding that the current forecast is close to the central bank’s target.
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.